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The American Society of Tropical Medicine and Hygiene is
the largest international scientific organization of experts
dedicated to reducing the worldwide burden of tropical in-
fectious diseases and improving global health. As leaders of
the society, we are compelled to speak up for the integrity of
science, and specifically for research funding and public
health decisions based on merit, with policies rooted in data.
Recently, key decisions have lacked this basis, and science is
under attack.
On April 24, 2020, the NIH abruptly canceled funding for an
ongoing program studying coronaviruses that had been fun-
ded since 2014. This decision was highly unusual for several
reasons. First, the NIH almost never cancels grants after
funding is approved based on rigorous peer review, unless
there is financial or scientific misconduct. Second, it is re-
markable that, of all grants to cancel in themidst of theCOVID-
19 pandemic, it is a grant to study coronaviruses. Third, it has
been substantiated that the decision to cancel the grant came
not from the NIH but from the highest levels of the U.S. gov-
ernment. There is little doubt that a productive research pro-
gram, indeed a program directly relevant to our attempts to
control the greatest respiratory virus pandemic of the last
century, was canceled because of political pressure. Can-
celing a major coronavirus research program at exactly the
time when more, not less, research in this area is needed is
deeply disturbing.
The research program that was canceled was led by the
EcoHealth Alliance, a U.S.-based global nonprofit organiza-
tion that conducts research on five continents in bio-
surveillance, deforestation, wildlife conservation, and, most
relevant to this conversation, zoonotic diseases and pan-
demicprevention. This research,which included collaboration
with other international institutions, focused on coronavirus
spread from bats to other species, including humans. The
research results contributed to studies to prevent the spread
of and to develop drugs and vaccines against SARS-CoV-2,
the cause of COVID-19.1 EcoHealth Alliance research has
helped us to understand howcoronaviruses jumped frombats
to humans to cause the current pandemic; the canceling of
this programwithout scientificbasis seemsa flagrant example
of “shooting the messenger.”
The reason for cutting the coronavirus researchproject is quite
transparent. The Trump administration reportedly learned about
the project, including its links to the Wuhan Institute of Virology,
from a reporter on April 17. Soon thereafter, it was announced
that the program would be cut. The Department of Health and
Human Services justified the cut with the claim that “the grantee
wasnot incompliancewithNIH’sgrantpolicy,”but thedirectorof
the NIH Institute that funded the study later stated in congres-
sional testimony that “it was canceled because the NIHwas told
to cancel it.” Clearly, the actual reason for cancellation was polit-
ical, apparently based on an attempt to assign blame for the
COVID-19pandemic toChina, and consistentwith claims that the
pandemic was the result of a laboratory accident or a deliberate
attempt to initiate a viral outbreak in Wuhan. These claims are
unsubstantiated and readily refuted by available molecular data.1
Onanother front, onMay29, theWhiteHouseannounced that
the United States will terminate its relationship with the WHO;
this was confirmed on July 6 when the United States sent an
official withdrawal letter to the United Nations. The WHO was
founded in 1948 to coordinate international health policy, es-
tablish global disease surveillance networks, and lead disease
control and eradication programs. It is supported by and under
thecontrol of its194memberstates.Althoughburdened through
its history by limited control over international health policy and
bureaucratic constraints, overall, theWHOhas been remarkably
successful and isanessential global institution.TheWHOplayed
a pivotal role in the eradication of smallpox, it has led successful
efforts to control and eliminate many other infectious diseases,
and it is the key international agency to lead efforts to address
international outbreak and epidemic diseases, from influenza to
HIV/AIDS, multidrug-resistant tuberculosis, polio, onchocerci-
asis, guinea worm, Ebola, Zika, and now COVID-19.
The reason for cutting ties with the WHO seems as clear as
that for the NIH grant cut described previously. With a failing
response to the COVID-19 pandemic at home and a pending
election, the U.S. administration acted to deflect criticism to
the WHO. Although initial international responses to the
emerging pandemic may have been slower than optimal, the
WHOplayed amajor role in rapid dissemination of information
regarding virus isolation and characterization within a few
weeks of recognition of the outbreak, oversaw the rapid de-
velopment of reliable tests for the infection, and has regularly
written and updated evidence-based guidance for control
of the pandemic. WHO coordination and strong national
programs and leadership are helping to curb COVID-19 in
many countries. As with cutting funding for coronavirus
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research during the pandemic, cutting funding for the WHO is
profoundly troubling.
At this time of deep human tragedy and economic disaster
due to the COVID-19 pandemic and of political upheaval in
many countries, the headlines change quickly, and politically
motivated mandates of great importance can fail to generate
the attention that they deserve. We have therefore highlighted
two recent decisions by the White House that are profoundly
misguided. Indeed, they seem the worst possible choices as
we grapple with an overwhelming pandemic. But these
choices can be reversed. We urge President Trump to 1) re-
instateandworkwithCongress to increase funding foressential
research on coronaviruses to help us develop new tools and
strategies to address current and future pandemics, and 2)
continue the country’s long-standing relationship with the
WHO, offering full financial support and cooperation for this
essential international body. More broadly, we implore our
electedofficialsat every level of government to keeppoliticsout
of decisions regarding medical research and public health. The
healthofAmericansandof thepopulationofourplanetmustnot
be a bargaining chip used to seek political gains or deflect ac-
countability. Rather, health is an indisputable human right. As
we fight the worst respiratory pandemic of the last century, it is
foolhardy to limit support for the best research and the best
publichealth institutions that areworking tostemthepandemic.
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